<DOC>
	<DOCNO>NCT00778284</DOCNO>
	<brief_summary>The objective study compare single-dose relative bioavailability Ranbaxy GlaxoSmithKline ( Augmentin® ) 400 mg amoxicillin ( trihydrate ) 57 mg clavulnic acid ( potassium salt ) chewable tablet , follow administration 2 tablet dose fed condition</brief_summary>
	<brief_title>Bioequivalence Study Amoxicillin 400 mg/Clavulanic Acid 57 mg Chewable Tablets Under Fed Conditions</brief_title>
	<detailed_description>The study conduct open-label , randomize , 2-way crossover study compare single-dose relative bioavailability Ranbaxy GlaxoSmithKline ( Augmentin® 40o mg ) amoxicillin ( trihydrate ) /57 mg clavulanic acid ( potassium salt ) chewable tablet , follow administration 2 tablet dose fed condition A total 40 Subjects , 20 male 20 female ; enrol study , 39 subject , 20 male 19 female , complete study .</detailed_description>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>1 . Healthy adult male female volunteer , 1855 year age 2 . Weighing least 52 kg male 45 kg female within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) ; 3 . Medically healthy subject clinically normal laboratory profile ; 4 . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior study throughout study use one follow acceptable birth control method : surgically sterile ( bilateral tubal ligation , hysterectomy bilateral oophorectomy ) 6 month minimum ; IUD place least 3 month ; barrier method ( condom , diaphragm ) spermicide least 14 day pror start study .throughout study ; surgical sterilization partner ( vasectomy 6 month minimum ) ; hormonal contraceptive least 3 month pdor start study . Other birth control method may deem acceptable . Postmenopausal woman amenorrhea least 2 year eligible ; 5 . Voluntarily consent participate study . Subject candidate must enrol study meet follow criterion : 1 . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease . 2 . In addition , history presence : alcoholism drug abuse within past 2 year ; hypersensitivity idiosyncratic reaction antibiotic , especially penicillins , cephalosporins amoxicillin and/or clavulanic acid 3 . Female subject pregnant lactating . 4 . Subjects abnormal diet ( whatever reason ) 30 day prior first dose . 5 . Subjects make donation ( standard donation amount ) blood blood product ( exception plasma note ) within 30 day prior study . 6 . Subjects make plasma donation within 7 day prior study 7 . Subjects participate another clinical trial within 30 day prior first dose .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence</keyword>
</DOC>